The net revenue for a textile plant was significantly lower than projected even though sales had increased. The company couldn’t find evidence of fraud and didn’t detect unusual trends in financial data, so it attributed the cause to accounting errors.
There were some minor inconsistencies in procurement of plant supplies, but the plant manager enforced strict controls, and validated purchases and requisitions each month. He hadn’t found any outliers. Though nobody discovered evidence on the surface,
Charles Washington, CFE, wasn’t convinced. His continued investigation into the small procurement inconsistency led to the identification of a major vendor fraud committed by the supply supervisor who maintained duplicate ledgers to conceal his crimes
from the plant manager and other executives. (Washington is now the senior director, global fraud and asset protection at Pfizer.)
For full access to story, members may
sign in here.
Not a
member? Click here to Join Now.
Or Click here to sign up for a FREE
TRIAL.